Cargando…

Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis

Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 mainly causes damage to the lung, as well as other organs and systems such as the hearts, the immune system and so on. Although the pathogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhongwen, Niu, Shuaishuai, Guo, Baojie, Gao, Tingting, Wang, Lei, Wang, Yukai, Wang, Liu, Tan, Yuanqing, Wu, Jun, Hao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645923/ https://www.ncbi.nlm.nih.gov/pubmed/33098357 http://dx.doi.org/10.1111/cpr.12939

Ejemplares similares

Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs
por: Wu, Jun, et al.
Publicado: (2020)

A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells
por: Gao, Tingting, et al.
Publicado: (2023)

Hyaluronate supports hESC‐cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction
por: Tan, Yuanqing, et al.
Publicado: (2020)

First case of COVID‐19 infused with hESC derived immunity‐ and matrix‐regulatory cells
por: Wu, Jun, et al.
Publicado: (2020)

Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis
por: Wu, Jun, et al.
Publicado: (2020)

Stem cell-based therapy for pulmonary fibrosis
por: Cheng, Wenzhao, et al.
Publicado: (2022)

From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
por: Michalski, Jacob E., et al.
Publicado: (2022)

Mechanosensitive ion channel Piezo1 mediates mechanical ventilation-exacerbated ARDS-associated pulmonary fibrosis
por: Fang, Xiang-Zhi, et al.
Publicado: (2022)

Glycyrrhizic Acid Inhibits Core Fucosylation Modification Modulated EMT and Attenuates Bleomycin-Induced Pulmonary Fibrosis
por: Gao, Lili, et al.
Publicado: (2022)

Six-Month Outcomes of Post-ARDS Pulmonary Fibrosis in Patients With H1N1 Pneumonia
por: Gao, Jing, et al.
Publicado: (2021)

Adenosine as pulmonary vasodilator in ARDS
por: Molina, JM, et al.
Publicado: (1998)

Pulmonary vascular dysfunction in ARDS
por: Ryan, Donal, et al.
Publicado: (2014)

Pulmonary infections complicating ARDS
por: Luyt, Charles-Edouard, et al.
Publicado: (2020)

Pharmacologic therapies of ARDS: From natural herb to nanomedicine
por: Meng, Linlin, et al.
Publicado: (2022)

Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice
por: Han, Meng-Meng, et al.
Publicado: (2023)

Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
por: Ntatsoulis, Konstantinos, et al.
Publicado: (2021)

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
por: Häberle, Helene, et al.
Publicado: (2021)

Future therapies for ARDS
por: Curley, Gerard F., et al.
Publicado: (2014)

Pulmonary fibrosis: Is stem cell therapy the way forward?
por: Ikrama, Muhammad, et al.
Publicado: (2023)

Generation of qualified clinical-grade functional hepatocytes from human embryonic stem cells in chemically defined conditions
por: Li, Zhongwen, et al.
Publicado: (2019)

A fully defined static suspension culture system for large-scale human embryonic stem cell production
por: Li, Xia, et al.
Publicado: (2018)

Correction: Generation of qualified clinical-grade functional hepatocytes from human embryonic stem cells in chemically defined conditions
por: Li, Zhongwen, et al.
Publicado: (2020)

Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside
por: Huang, Teng, et al.
Publicado: (2022)

Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT
por: Mineo, G., et al.
Publicado: (2011)

Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mouse models of pulmonary fibrosis through different routes
por: Yang, Shengnan, et al.
Publicado: (2022)

TLQP-21 modulate inflammation and fibrosis in a model of ards
por: Pozzi, F, et al.
Publicado: (2015)

Editorial: Personalized therapy in ARDS
por: Battaglini, Denise, et al.
Publicado: (2023)

Hemodynamic profile of pulmonary hypertension (PH) in ARDS
por: Calcaianu, George, et al.
Publicado: (2017)

The Safety and Efficiency of Addressing ARDS Using Stem Cell Therapies in Clinical Trials
por: Rezoagli, Emanuele, et al.
Publicado: (2019)

Stem cell-based therapy for COVID-19 and ARDS: a systematic review
por: Zanirati, Gabriele, et al.
Publicado: (2021)

Mesenchymal stem cells and their derived exosomes for ALI/ARDS: A promising therapy
por: Liang, Dan, et al.
Publicado: (2023)

Pulmonary artery targeted therapy in treatment of COVID-19 related ARDS. Literature review
por: Puk, Oskar, et al.
Publicado: (2022)

Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
por: Wang, Zi-Hao, et al.
Publicado: (2023)

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis
por: Yang, Shengnan, et al.
Publicado: (2021)

Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)

Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination
por: Chuang, Hong-Meng, et al.
Publicado: (2018)

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019)

Oxygenation response to prone positioning in pulmonary and extrapulmonary ARDS
por: Akinci, O, et al.
Publicado: (2000)

Expiratory pressure-volume curves in pulmonary and extrapulmonary ARDS
por: Muñiz Albaiceta, G, et al.
Publicado: (2002)

Pulmonary lactate production in septic patients with and without ARDS
por: Silva, E, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_fhp5hvja3btflsm6a41j0go4v8